IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
-5.26%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$329M
AUM Growth
+$329M
(-5.9%)
Cap. Flow
+$40M
Cap. Flow
% of AUM
12.16%
Top 10 Holdings %
Top 10 Hldgs %
37.77%
Holding
184
New
15
Increased
124
Reduced
12
Closed
9
Top Buys
| 1 |
SAGE
Sage Therapeutics
SAGE
|
$8.27M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$7.11M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$6.52M |
| 4 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$6.34M |
| 5 |
BLU
BELLUS Health Inc.
BLU
|
$5.94M |
Top Sells
| 1 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$11.3M |
| 2 |
Biogen
BIIB
|
$6M |
| 3 |
BCYC
Bicycle Therapeutics
BCYC
|
$5.89M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$3.95M |
| 5 |
iShares Biotechnology ETF
IBB
|
$3.67M |
Sector Composition
| 1 | Healthcare | 98.75% |
| 2 | Consumer Staples | 0.62% |
| 3 | Technology | 0.36% |
| 4 | Financials | 0.23% |
| 5 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCYC
1
Bicycle Therapeutics
BCYC
$511M
| $21M | 2.76% | 478,784 -134,342 | -22% | -$5.89M |
|
2
Celldex Therapeutics
CLDX
$1.47B
| $18.3M | 2.41% | 537,958 +118,742 | +28% | +$4.04M |
|
3
Kezar Life Sciences
KZR
$28.9M
| $18M | 2.37% | 1,083,116 +62,199 | +6% | +$1.03M |
|
4
Milestone Pharmaceuticals
MIST
$156M
| $12.4M | 1.63% | 1,928,752 +178,709 | +10% | +$1.15M |
|
|
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $11.6M | 1.52% | 110,116 +34,455 | +46% | +$3.62M |
|
6
Adicet Bio
ACET
$59.9M
| $10.1M | 1.33% | 507,348 +29,930 | +6% | +$598K |
|
7
Zentalis Pharmaceuticals
ZNTL
$122M
| $9.33M | 1.23% | 202,203 +11,063 | +6% | +$510K |
|
|
SAGE
8
DELISTED
Sage Therapeutics
SAGE
| $8.27M | 1.09% | +249,907 | New | +$8.27M |
|
9
Vaxcyte
PCVX
$4B
| $7.63M | 1% | 315,991 +20,880 | +7% | +$504K |
|
|
TCON
10
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $7.48M | 0.98% | 2,843,232 +152,122 | +6% | +$400K |
|
11
Xenon Pharmaceuticals
XENE
$2.98B
| $7.32M | 0.96% | 239,441 +60,303 | +34% | +$1.84M |
|
|
BHVN
12
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $7.11M | 0.94% | +60,000 | New | +$7.11M |
|
|
SRRA
13
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $6.98M | 0.92% | 217,915 -351,114 | -62% | -$11.3M |
|
14
Gossamer Bio
GOSS
$562M
| $6.73M | 0.89% | 775,315 -391,618 | -34% | -$3.4M |
|
|
15
Vertex Pharmaceuticals
VRTX
$100B
| $6.52M | 0.86% | +25,000 | New | +$6.52M |
|
16
Rigel Pharmaceuticals
RIGL
$697M
| $6.39M | 0.84% | 2,137,128 +1,697,772 | +386% | +$5.08M |
|
|
KRTX
17
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $6.34M | 0.83% | +50,000 | New | +$6.34M |
|
|
BLU
18
DELISTED
BELLUS Health Inc.
BLU
| $6.28M | 0.83% | 913,327 +863,327 | +1,727% | +$5.94M |
|
19
Immatics
IMTX
$619M
| $6.24M | 0.82% | 781,388 +43,842 | +6% | +$350K |
|
20
Seres Therapeutics
MCRB
$166M
| $5.99M | 0.79% | 840,624 +44,721 | +6% | +$318K |
|
21
scPharmaceuticals
SCPH
$295M
| $5.51M | 0.72% | 970,098 +68,736 | +8% | +$390K |
|
22
Galapagos
GLPG
$2.07B
| $5.41M | 0.71% | 86,865 | – | – |
|
23
Amylyx Pharmaceuticals
AMLX
$836M
| $5.1M | 0.67% | +396,654 | New | +$5.1M |
|
24
Amgen
AMGN
$155B
| $4.84M | 0.64% | +20,000 | New | +$4.84M |
|
25
Pfizer
PFE
$141B
| $4.14M | 0.54% | +80,000 | New | +$4.14M |
|